{
    "maintainer": null,
    "private": false,
    "maintainer_email": null,
    "revision_timestamp": null,
    "keywords": [
        {
            "display_name": "medicines",
            "name": "medicines"
        },
        {
            "display_name": "diseases",
            "name": "diseases"
        },
        {
            "display_name": "World Health Organization",
            "name": "World Health Organization"
        },
        {
            "display_name": "public health",
            "name": "public health"
        }
    ],
    "metadata_modified": "2019-01-09 16:47:43.767635",
    "temporal_granularity": "",
    "concepts_eurovoc": [
        "http://eurovoc.europa.eu/2144",
        "http://eurovoc.europa.eu/1852",
        "http://eurovoc.europa.eu/4635"
    ],
    "license_id": null,
    "type": "dataset",
    "resources": [
        {
            "mimetype": null,
            "mimetype_inner": "",
            "hash": "",
            "description": "The European Medicines Agency (EMA), in cooperation with the World Health Organization (WHO), can provide scientific opinions on high priority human medicines, including vaccines, that are intended exclusively for markets outside of the European Union (EU).\r\n\r\nThe aim is to facilitate patient access to essential medicines in low- and middle-income countries, including new or improved therapies for unmet medical needs, which are intended to prevent or treat diseases of major public health interest.",
            "format": "http://publications.europa.eu/resource/authority/file-type/HTML",
            "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000312.jsp&mid=WC0b01ac058001d12c",
            "created": "2016-06-22 11:08:58.802286",
            "tracking_summary": null,
            "name": "Opinions on medicines for use outside the European Union",
            "state": "http://publications.europa.eu/resource/authority/dataset-status/COMPLETED",
            "last_modified": "",
            "download_total_resource": "11",
            "url_type": null,
            "position": null,
            "iframe_code": "",
            "datastore_active": false,
            "id": "http://data.europa.eu/88u/distribution/98dea17b-3e6c-4544-b776-5c035e61b2da",
            "resource_type": "http://publications.europa.eu/resource/authority/distribution-type/WEB_SERVICE",
            "size": ""
        },
        {
            "mimetype": null,
            "mimetype_inner": null,
            "hash": "",
            "description": "Opinions on medicines for use outside the European Union are given in accordance with Article 58 of Regulation (EC) No 726/2004. ",
            "format": "http://publications.europa.eu/resource/authority/file-type/HTML",
            "url": "http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0001:0033:en:PDF",
            "created": null,
            "tracking_summary": null,
            "name": " Regulation (EC) No 726/2004",
            "state": null,
            "last_modified": null,
            "download_total_resource": null,
            "url_type": null,
            "position": null,
            "iframe_code": null,
            "datastore_active": false,
            "id": "http://data.europa.eu/88u/document/999bcba5-48c8-4897-8094-f966e6e583da",
            "resource_type": "http://publications.europa.eu/resource/authority/documentation-type/DOCUMENTATION_MAIN",
            "size": null
        },
        {
            "mimetype": null,
            "mimetype_inner": null,
            "hash": "",
            "description": "The European Medicines Agency (EMA), in cooperation with the World Health Organization (WHO), can provide scientific opinions on high priority human medicines, including vaccines, that are intended exclusively for markets outside of the European Union (EU).\r\n\r\nThe aim is to facilitate patient access to essential medicines in low- and middle-income countries, including new or improved therapies for unmet medical needs, which are intended to prevent or treat diseases of major public health interest.",
            "format": "http://publications.europa.eu/resource/authority/file-type/HTML",
            "url": "https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/medicines-use-outside-european-union",
            "created": null,
            "tracking_summary": null,
            "name": "Medicines for use outside the European Union",
            "state": null,
            "last_modified": null,
            "download_total_resource": null,
            "url_type": null,
            "position": null,
            "iframe_code": null,
            "datastore_active": false,
            "id": "http://data.europa.eu/88u/document/4a5fe14d-1f8c-476e-a1ba-077b7689be8e",
            "resource_type": "http://publications.europa.eu/resource/authority/documentation-type/DOCUMENTATION_MAIN",
            "size": null
        }
    ],
    "interoperability_level": null,
    "name": "medicines-for-use-outside-the-eu",
    "isopen": true,
    "accrual_periodicity": "",
    "owner_org": "cc9851fa-c87a-4be0-ada7-573e1a6aad2e",
    "geographical_coverage": [
        "http://publications.europa.eu/resource/authority/country/ROU",
        "http://publications.europa.eu/resource/authority/country/SVK",
        "http://publications.europa.eu/resource/authority/country/SVN",
        "http://publications.europa.eu/resource/authority/country/SWE",
        "http://publications.europa.eu/resource/authority/country/MLT",
        "http://publications.europa.eu/resource/authority/country/NLD",
        "http://publications.europa.eu/resource/authority/country/POL",
        "http://publications.europa.eu/resource/authority/country/PRT",
        "http://publications.europa.eu/resource/authority/country/BEL",
        "http://publications.europa.eu/resource/authority/country/AUT",
        "http://publications.europa.eu/resource/authority/country/CYP",
        "http://publications.europa.eu/resource/authority/country/BGR",
        "http://publications.europa.eu/resource/authority/country/DEU",
        "http://publications.europa.eu/resource/authority/country/CZE",
        "http://publications.europa.eu/resource/authority/country/ESP",
        "http://publications.europa.eu/resource/authority/country/DNK",
        "http://publications.europa.eu/resource/authority/country/FIN",
        "http://publications.europa.eu/resource/authority/country/EST",
        "http://publications.europa.eu/resource/authority/country/GBR",
        "http://publications.europa.eu/resource/authority/country/FRA",
        "http://publications.europa.eu/resource/authority/country/HRV",
        "http://publications.europa.eu/resource/authority/country/GRC",
        "http://publications.europa.eu/resource/authority/country/IRL",
        "http://publications.europa.eu/resource/authority/country/HUN",
        "http://publications.europa.eu/resource/authority/country/LTU",
        "http://publications.europa.eu/resource/authority/country/ITA",
        "http://publications.europa.eu/resource/authority/country/LVA",
        "http://publications.europa.eu/resource/authority/country/LUX"
    ],
    "revision_id": null,
    "identifier": "",
    "version_description": "",
    "extras": [],
    "relationships_as_object": [],
    "tag_string": null,
    "temporal_coverage_to": "",
    "num_tags": null,
    "id": "medicines-for-use-outside-the-eu",
    "metadata_created": "2016-06-22 09:03:51.117177",
    "modified_date": "2019-01-09 16:47:43.767635",
    "capacity": "public",
    "author": null,
    "author_email": null,
    "type_of_dataset": [],
    "state": null,
    "version": "",
    "creator_user_id": null,
    "status": "http://data.europa.eu/euodp/kos/dataset-status/Completed",
    "num_resources": 1,
    "description": "This page lists the opinions given by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), in co-operation with the World Health Organization (WHO), on medicines for human use that are intended exclusively for markets outside of the European Union (EU).\r\n\r\nThese opinions are given in accordance with Article 58 of Regulation (EC) No 726/2004. \r\n\r\nPublic assessment reports can be downloaded in the PDF format. ",
    "title": "Medicines for use outside the EU",
    "temporal_coverage_from": "",
    "groups": [
        {
            "title": "http://publications.europa.eu/resource/authority/data-theme/TECH"
        }
    ],
    "relationships_as_subject": [],
    "language": [
        "http://publications.europa.eu/resource/authority/language/ENG"
    ],
    "alternative_title": "",
    "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000312.jsp&mid=WC0b01ac058001d12c",
    "release_date": "2016-06-22 09:03:51.117177",
    "license_title": null,
    "rdf": null,
    "license_url": "http://data.europa.eu/euodp/kos/licence/EuropeanCommission",
    "organization": {
        "name": "emea",
        "title": "European Medicines Agency"
    }
}